Irina Zhou’s five-year-old cat has gained about a kilogram every year for the past three years. She knows the extra…
Read More »Eli Lilly
The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28…
Read More »“Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose…
Read More »Mainland China’s 17 million Alzheimer’s patients can, for the first time, pay less out of pocket for a costly drug…
Read More »Hong Kong’s booming fundraising market is set for another busy week, with four companies scheduled to debut this week and…
Read More »American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…
Read More »When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…
Read More »The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…
Read More »






